Predict your next investment

Private Equity
qcapital.co.kr

See what CB Insights has to offer

Investments

24

Portfolio Exits

1

Funds

1

About Q Capital Partners

Q Capital Partners (KOSDAQ: 016600) is a private equity and venture capital firm specializing in corporate restructurings, buyouts, and venture capital investments.

Q Capital Partners Headquarter Location

Seoul,

South Korea

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Q Capital Partners News

Q Capital Partners Acquires 44.68% Stake in South Korea’s Seoul Pharma for USD37m

Mar 17, 2020

Q Capital Partners Acquires 44.68% Stake in South Korea’s Seoul Pharma for USD37m Posted On: 12 Mar 2020 |Source(s): the bell South Korea-based PE fund Q Capital Partners has acquired a 44.68% stake in pharmaceutical company Seoul Pharma for KRW45b (approximately USD37m). Read more Join today for exclusive benefits. EMPEA is the global industry association for private capital in emerging markets. Subscribers can take advantage of special offers made by EMPEA or our partner companies. Click here to sign up . In addition to these great free features, subscribers also have access to: Weekly emerging markets private capital newsletter, NewsWatch Invitations to industry events worldwide and in your market Sector- and region-specific special reports and data releases

Q Capital Partners Investments

24 Investments

Q Capital Partners has made 24 investments. Their latest investment was in SANDBOX NETWORK as part of their Series D on November 11, 2020.

CBI Logo

Q Capital Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/20/2020

Series D

SANDBOX NETWORK

$43.99M

Yes

1

8/10/2020

Private Equity

NOLBAL

$16.86M

Yes

1

3/17/2020

Corporate Minority

Seoul Pharmaceuticals

$37M

Yes

1

12/20/2019

Series A

Subscribe to see more

$99M

Subscribe to see more

10

4/8/2019

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/20/2020

8/10/2020

3/17/2020

12/20/2019

4/8/2019

Round

Series D

Private Equity

Corporate Minority

Series A

Series C

Company

SANDBOX NETWORK

NOLBAL

Seoul Pharmaceuticals

Subscribe to see more

Subscribe to see more

Amount

$43.99M

$16.86M

$37M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

1

10

10

Q Capital Partners Portfolio Exits

1 Portfolio Exit

Q Capital Partners has 1 portfolio exit. Their latest portfolio exit was MINDs Lab on November 23, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

11/23/2021

IPO

1

Date

11/23/2021

Exit

IPO

Companies

Valuation

Acquirer

Sources

1

Q Capital Partners Fund History

1 Fund History

Q Capital Partners has 1 fund, including KoFC QCP IBKC Frontier Champ 2010-2 PEF.

Closing Date

Fund

Fund Type

Status

Amount

Sources

11/30/2010

KoFC QCP IBKC Frontier Champ 2010-2 PEF

Expansions & Growth

$287.24M

1

Closing Date

11/30/2010

Fund

KoFC QCP IBKC Frontier Champ 2010-2 PEF

Fund Type

Expansions & Growth

Status

Amount

$287.24M

Sources

1

Q Capital Partners Team

1 Team Member

Q Capital Partners has 1 team member, including current Chief Executive Officer, Eun-Sang Yoo.

Name

Work History

Title

Status

Eun-Sang Yoo

Chief Executive Officer

Current

Name

Eun-Sang Yoo

Work History

Title

Chief Executive Officer

Status

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.